What's new

EMEA-001949-PIP01-16-M06

EMEA-001949-PIP01-16-M06

Mar 14, 2025 - 10:59
 0
EMEA-001949-PIP01-16-M06
EMEA-001949-PIP01-16-M06
Read More

Tags:

Previous Article

SEAT EV vision: roadmap is flexible, the target is steadfast

Next Article

Guess and WHP strike licensing deal for Rag & Bone accessories

Related Posts

Human medicines European public assessment report (EPAR): Ravicti, glycerol phenylbutyrate, Date of authorisation: 26/11/2015, Revision: 18, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 18, 2025  0

Opinion/decision on a Paediatric investigation plan (PIP): Opsumit, Macitentan, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Cardiac disorders, PIP number: P/0457/2023

Opinion/decision on a Paediatric investigation plan (PI...

Mar 6, 2025  0

Product Management Service (PMS) questions and aswers clinic - April 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 29 April 2025, 11:00 (CEST) to 29 April 2025, 12:00 (CEST)

Product Management Service (PMS) questions and aswers c...

Mar 7, 2025  0